Propiedad intelectual y salud pública
Documentos
-
CIPIH Hollis Me-too
pdf, 143kb -
Ownership of knowledge- the role of patents in pharmaceutical R&D |Carlos María Correa| 2004
-
Draft: Size and duration effects of post-patent pharmaceutical pricing: Evidence from patent data | Alan C. Marco | April 10, 2004
- "Me-Too" Products — Friend or Foe? | Thomas H. Lee | 15 January 2004
- Correspondence- "Me-Too" Products — Friend or Foe?
-
An Efficient Reward System for Pharmaceutical Innovation | Aidan Hollis | Draft – updated 24.11.2004
-
The Economics of Follow-on Drug Research and Development | Joseph A. DiMasi and Cherie Paquette |2004
-
To Promote Innovation: The Propert Balance of Competition and Patent Law and Policy | Federal Trade Commission | October 2003
- Pharmaceutical Pricing in a Regulated Market | Mats Ekelund and Björn Persson | May 2003
-
Changing Patterns of Pharmaceutical Innovation | NIHCM Foundation | May 2002
-
NIHCM’s Report on Pharmaceutical Innovation: Fact vs. Fiction: A Preliminary Report by PhRMA | PhRMA | June 11, 2002
-
The NIHCM Foundation Responds to PhRMA’s Criticisms of the Report, “Changing Patterns of Pharmaceutical Innovation” | NIHCM Foundation | June 13, 2002
-
NIHCM Report on Pharmaceutical Innovation: NIHCM Response to PhRMA Rebuttal is Silent on the Real Issues | PhRMA
-
Pharmaceutical knowledge-capital accumulation and longevity | Frank R. Lichtenberg | Revised October 2002
-
Generic Drug Entry Prior to Patent Expiration: An FTC Study | Federal Trade Commission | July 2002
-
CIPIH Too Many Drugs
pdf, 249kb - Strategic Pricing of New Pharmaceuticals | Z. John Lu and William S. Comanor | February 1998
-
Price trends for prescriptions: pharmaceuticals 1995-1999| Joseph A. DiMasi, Ph.D.
- Government of Canada Proposes Amendments to Intellectual Property Rules for Pharmaceuticals| Industry Canada | December 13, 2004